期刊文献+

人胚胎骨髓间充质干细胞的增殖能力及其向三个胚层起源细胞分化的特性 被引量:3

Proliferative capacity of mesenchymal stem cells from human fetal bone marrow and their ability to differentiate into the derivative cell types of three embryonic germ layers
暂未订购
导出
摘要 为探讨人胚胎骨髓间充质干细胞(mesenchymal stem cells from human fetal bone marrow,hfBM-MSCs)的增殖能力及其向三个胚层起源细胞分化的"类胚胎干细胞"特性,本文利用细胞差速贴壁生长特性分离纯化hfBM-MSCs,用流式细胞仪检测hfBM-MSCs的细胞周期和MSCs特异的表面标志;用免疫细胞化学方法和RT-PCR法分别在蛋白和RNA水平检测人端粒酶逆转录酶(human telomerase reverse transcriptase,hTERT)和胚胎干细胞特异性抗原Oct4、SSEA-4的表达;用各种化学试剂诱导hfBM-MSCs向神经元、脂肪细胞和胰岛B细胞分化并加以鉴定。流式细胞仪检测结果显示,第4、5代hfBM-MSCs分别有92.3%和96.1%的细胞处于G0/G1期;这些细胞表达CD29、CD44和CD106,不表达造血细胞标志CD34和CD45,极低地表达与移植物抗宿主病(graft-versus-host disease,GVHD)相关的HLA-DR、CD40和CD80。免疫细胞化学和RT-PCR结果显示,hfBM-MSCs表达Oct4、SSEA-4等胚胎干细胞标志,hTERT也呈阳性表达。在特定诱导条件下,hfBM-MSCs可分化为神经元样细胞(外胚层)、脂肪样细胞(中胚层)和胰岛B样细胞(内胚层)。因此,人胚胎骨髓中含有丰富的MSCs,hfBM-MSCs具有胚胎干细胞的主要生物学特性,且免疫原性弱,是组织工程和细胞治疗较为理想的种子细胞。 Strong proliferative capacity and the ability to differentiate into the derivative cell types of three embryonic germ layers are the two important characteristics of embryonic stem cells. To study whether the mesenchymal stem cells from human fetal bone marrow (hfBM-MSCs) possess these embryonic stem cell-like biological characteristics, hfBM-MSCs were isolated from bone barrows and further purified according to the different adherence of different kinds of cells to the wall of culture flask. The cell cycle of hfBM-MSCs and MSC-specific surface markers such as CD29, CD44, etc were identified using flow cytometry. The expressions of human telomerase reverse transcriptase (hTERT), the embryonic stem cell-specific antigens, such as Oct4 and SSEA-4 were detected with immunocytochemistry at the protein level and were also tested by RT-PCR at the mRNA level. Then, hfBM-MSCs were induced to differentiate toward neuron cells, adipose cells, and islet B cells under certain conditions. It was found that 92.3% passage-4 hfBM- MSCs and 96.1% passage-5 hfBM-MSCs were at G0/G1 phase respectively, hfBM-MSCs expressed CD44, CD 106 and adhesion molecule CD29, but not antigens of hematopoietic cells CD34 and CD45, and almost not antigens related to graft-versus-host disease (GVHD), such as HLA-DR, CD40 and CD80. hfBM-MSCs expressed the embryonic stem cell-specific antigens such as Oct4, SSEA-4,and also hTERT. Exposure of these cells to various inductive agents resulted in morphological changes towards neuron-like cells, adipose-like cells, and islet B-like cells and they were tested to be positive for related characteristic markers. These results suggest that there are plenty of MSCs in human fetal bone marrow, and hfBM-MSCs possess the embryonic stem cell-like biological characteristics, moreover, they have a lower immunogenic nature. Thus, hfBM-MSCs provide an ideal source for tissue engineering and cellular therapeutics.
作者 王跃春 张洹
出处 《生理学报》 CAS CSCD 北大核心 2008年第3期425-430,共6页 Acta Physiologica Sinica
基金 the Key Subject Construction Foundation of the State Council of China (No. 2005) the DoctorDegree Dissertation Innovation Foundation of Jinan University (No. 52005031)
关键词 胎儿 骨髓 间充质干细胞 胚胎干细胞 fetus bone marrow mesenchymal stem cells embryonic stem cell
  • 相关文献

参考文献13

  • 1Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004; 23: 7150-7160.
  • 2Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr Rev 2006; 27: 208-219.
  • 3Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11(5): 321-334.
  • 4In't Anker PS, Noon WA, Scherjon SA, Kleijburg-vander Keur CK, Kruisselbrink AB, van Bezooijen RL, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003; 88(8):845-852.
  • 5吴北燕,黄绍良,陈惠芹,张绪超,魏菁.胎肝造血期胎肝间充质干细胞的分离、培养及生物学特性[J].中山大学学报(医学科学版),2005,26(5):498-501. 被引量:7
  • 6Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largeespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418 (6893): 41-49.
  • 7McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, Tilton R, Denner L. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 2005; 38: 245-255.
  • 8Zhao Y, Wang H, Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 2006; 312: 2454-2464.
  • 9Sun B, Roh KH. Lee SR, Lee YS, Kang KS. Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Commun 2007; 354: 919-923.
  • 10Gerrard L, Zhao D, Clark A J, Cui W. Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 2005; 23: 124.

二级参考文献8

  • 1赵运转,魏来,韩梅,李凌松.胎肝来源间充质干细胞的分离、培养与多向分化[J].中华肝脏病杂志,2004,12(12):711-713. 被引量:4
  • 2Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem ceils [J].Science, 1999,284(5411):143-7.
  • 3Seshi B, Kumar S, Sellers D, et al. Human bone marrow stromal cells: coexpression of marker specific for multiple mesenchymal cell lineages[J]. Blood Cells Mol Dis,2000, 26(3): 234-46.
  • 4Gotherstrom C, Ringden O, Tammik C, et al. Immunologic properties of human fetal mesenchymal stem cells[J]. Am J Obstet Gynecol, 2004, 190(1):239-45.
  • 5in't Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem ceils in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differetiation potential[J]. Haematologica, 2003, 88 (8):845-52.
  • 6Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stendprogenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].Blood, 2001, 98(8):2396-402.
  • 7陈纯.CD40-CD40L在移植免疫中的研究进展[J].国外医学(输血及血液学分册),2001,24(3):217-220. 被引量:7
  • 8周敦华,黄绍良,吴燕峰,魏菁,陈戈煜,黎阳,包蓉.人间充质干细胞体外扩增及生物学特性的研究[J].中华儿科杂志,2003,41(8):607-610. 被引量:31

共引文献6

同被引文献43

  • 1王玉英,胡涛,贾国良,王海昌,田琼,李寰.银杏叶提取物对人脐静脉内皮细胞增殖的影响[J].第四军医大学学报,2004,25(13):1179-1181. 被引量:20
  • 2Xiao-chunCHEN Yi-canZHOU YingCHEN Yuan-guiZHU FangFANG Li-minCHEN.Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress[J].Acta Pharmacologica Sinica,2005,26(1):56-62. 被引量:38
  • 3吕璐璐,刘拥军,许贞书,王彤,张浪辉,朱雄鹏,梁琳慧,王晗,陈志哲,韩忠朝.脐带源间充质干细胞的分离和生物学性状[J].福建医科大学学报,2006,40(2):99-104. 被引量:38
  • 4Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292 (5520): 1389-1394.
  • 5Kim D, Gu Y, lshii M, Fujimiya M, Qi M, Nakamura N, Yoshikawa T, Sumi S, Inoue K. In vivo functioning and transplantable mature pancreatic islet-like cell clusters differentiated from embryonic stem cell. Pancreas 2003; 27(2): 34-41.
  • 6Chang CM, Kao CL, Chang YL, Yang M J, Chen YC, Sung BL, Tsai TH, Chao KC, Chiou SH, Ku HH. Placenta-derived multipotent stem cells induced to differentiate into insulinpositive cells. Biochem Biophys Res Commun 2007; 357(2): 414-420.
  • 7Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA 2002; 99(25): 16105-16110.
  • 8Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23 (2): 220-229.
  • 9Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25 (6): 1384-1392.
  • 10Kim JH, Park SN, Suh H. Generation of insulin-producing human mesenchymal stem cells using recombinant adenoassociated virus. Yonsei Med J 2007; 48(1): 109-119.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部